Abstract
A novel type of biocompatible hollow capsules that combine severable favorable features as a hydrophobic drug carrier, including host–guest complexation in the shell, the unique biological functions of hyaluronic acid (HA), and transport properties of the multilayer shell, was designed and prepared. These capsules were generated by layer-by-layer (LbL) deposition of HA modified with β-cyclodextrin (CD) molecules and poly(l-lysine) (PLL) on calcium carbonate particles. Simultaneously, paclitaxel (PTX) was loaded in the LbL wall via host–guest interaction. Under physiological conditions, the incorporated anticancer drug was slowly released, and the capsules remained stable. Because the PTX molecules are selectively complexed by CD in the shell, their release can be triggered by the addition of competitive cyclodextrin molecules in the external medium. By incubating the capsules with breast cancer cells (MDA-MB-231), it was found that the cells bound specifically to the capsules through the CD44 receptor of ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
